The potentiation of 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity by tamoxifen in female CD1 mice

This publication has 15 references indexed in Scilit:

• Endocrine Treatment of Breast Cancer in Women
  Endocrine Reviews, 1990
• 2,3,7,8-Tetrachlorodibenzo-p-dioxin pretreatment of female mice altered tissue distribution but not hepatic metabolism of a subsequent dose
  Fundamental and Applied Toxicology, 1990
• Life threatening interaction between tamoxifen and warfarin.
  BMJ, 1989
• Effects of 2,3,7,8‐Tetrachlorodibenzo‐p‐dioxin (TCDD) on de novo fatty acid and cholesterol synthesis in the rat
  Lipids, 1988
• A physiologically based pharmacokinetic model for 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice
  Toxicology Letters, 1988
• Interaction between tamoxifen and digitoxin?
  Journal of Molecular Medicine, 1986
• Tamoxifen and liver damage.
  BMJ, 1984
• The pharmacology and clinical uses of tamoxifen
  Pharmacology & Therapeutics, 1984
• 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of Toxicity
  Annual Review of Pharmacology and Toxicology, 1982
• Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats
  Toxicology and Applied Pharmacology, 1978